Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) represents a broad spectrum of chronic liver disease characterized by aberrant accumulation of triglycerides (TG) in hepatocytes without excessive alcohol consumption. Hepatic lipotoxicity derived from overaccumulation of free fatty acids...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lin, Zhang, Xiujuan, Zhang, Li, Zheng, Dongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547785/
https://www.ncbi.nlm.nih.gov/pubmed/33116702
http://dx.doi.org/10.2147/DMSO.S262284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547785/
https://www.ncbi.nlm.nih.gov/pubmed/33116702
http://dx.doi.org/10.2147/DMSO.S262284

Ejemplares similares